Lido Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-667
| Closed | -$5.42K | – | 1123 |
|
|
2023
Q1 | $5.42K | Hold |
667
| – | – | ﹤0.01% | 980 |
|
|
2022
Q4 | $7.91K | Hold |
667
| – | – | ﹤0.01% | 842 |
|
|
2022
Q3 | $9K | Hold |
667
| – | – | ﹤0.01% | 824 |
|
|
2022
Q2 | $23K | Hold |
667
| – | – | ﹤0.01% | 808 |
|
|
2022
Q1 | $26K | Hold |
667
| – | – | ﹤0.01% | 866 |
|
|
2021
Q4 | $28K | Hold |
667
| – | – | ﹤0.01% | 868 |
|
|
2021
Q3 | $45K | Hold |
667
| – | – | ﹤0.01% | 842 |
|
|
2021
Q2 | $51K | Hold |
667
| – | – | ﹤0.01% | 781 |
|
|
2021
Q1 | $44K | Hold |
667
| – | – | ﹤0.01% | 729 |
|
|
2020
Q4 | $22K | Hold |
667
| – | – | ﹤0.01% | 703 |
|
|
2020
Q3 | $37K | Hold |
667
| – | – | ﹤0.01% | 552 |
|
|
2020
Q2 | $25K | Hold |
667
| – | – | ﹤0.01% | 517 |
|
|
2020
Q1 | $17K | Buy |
+667
| New | +$17K | ﹤0.01% | 515 |
|